Polyspecific snake antivenom may help in antivenom crisis [4]

British Medical Journal

Volumn 326, Issue 7386, 2003, Pages 447-448

  Laing, G D ^a   Harrison, R A ^a   Theakston, R D G ^a   Renjifo, J M ^b   Nasidi, A ^c   Gutierrez, J M ^d   Warrell, D A ^e  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b INSTITUTO NACIONAL DE SALUD   (Colombia)

^c Federal Ministry of Health   (Nigeria)

^d UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM ANTISERUM;

AFRICA; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRISIS INTERVENTION; DRUG EFFICACY; DRUG POTENCY; HUMAN; LETTER; MORTALITY; NIGERIA; NONHUMAN; PHYSICAL DISABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SNAKEBITE; SPECIES; WORLD HEALTH ORGANIZATION;

AFRICA; ANTIVENINS; HUMANS; SNAKE BITES; SPECIES SPECIFICITY;

EID: 0037460726     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Theakston RDG, Warrell DA. Crisis in snake antivenom supply for Africa. Lancet 2000;356:2104.
2. World Health Organization. Report of a WHO workshop on the standardization and control of antivenoms. Geneva: WHO (in press). (Workshop held 7-9 February 2001.)
3. World Health Organization. Progress in the characterization of venoms and standardization of antivenoms. Geneva: WHO, 1981. (WHO offset publication No 58.)
4. Meyer WP, Habib HG, Onayade AA, Yakubu A, Smith DC, Nasidi A, et al. First clinical experience with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomised comparative trial with Institute Pasteur serum (Ipser) African antivenom. Am J Trop Med Hyg 1997;56:291-303.